smoking, country of birth, and delivery year. Stillbirth and neonatal death were retrieved from the Swedish Medical Birth Register. Results: Before surgery, the mean BMI was 43.1 (SD 5.3) and 9.6% had diabetes. The median surgery-to-conception-interval was 2.6 years (IQR 1.6-4.0), and the mean weight loss between surgery and early-pregnancy was 39kg (SD 13). The risk of stillbirth after gastric bypass was 0.5% [27/5110] versus 0.5% in matched controls (adjusted risk ratio [aRR] 1.02, 95%CI 0.62-1.68; P50.95). The corresponding risks for neonatal death were 0.3% [16/5083] vs 0.2% (aRR 1.39, 95%CI 0.66-2.93; P50.39) and for the combined outcome stillbirth plus neonatal death 0.8% [43/5110] vs 0.7% (aRR 1.13, 95%CI 0.75-1.71; P50.55). Conclusions: Maternal gastric bypass was not associated with a higher risk of stillbirth or neonatal death compared to women matched on age, BMI, diabetes, smoking, parity and country of birth.
smoking, country of birth, and delivery year. Stillbirth and neonatal death were retrieved from the Swedish Medical Birth Register. Results: Before surgery, the mean BMI was 43.1 (SD 5.3) and 9.6% had diabetes. The median surgery-to-conception-interval was 2.6 years (IQR 1.6-4.0), and the mean weight loss between surgery and early-pregnancy was 39kg (SD 13) . The risk of stillbirth after gastric bypass was 0.5% [27/5110] Results: 59 patients were identified for inclusion within the database. The Mean BMI at baseline was 52.2. The highest BMI was 67 and the lowest BMI was 41. 30 day and 1 year mortality rate was 0%. 30 day readmission rate was 5%. 30 day reoperation rate was 3.3%. 6 month mean excess weight loss was 61%. 6 month resolution of diabetes was 60%. 1 year mean excess weight loss was 81%. 1 year resolution of diabetes was 80%. At 1 year, participants had an average change in BMI of 23. The follow-up rate at 1 year was 75%. 6.7% required significant intervention such as total parental nutrition (TPN) or feeding tube placement due to malabsorption and vitamin deficiencies experienced within the first year. Conclusion: The LOOP DS procedure demonstrates successful weight loss and diabetes resolution as an alternative to sleeve gastrectomy and gastric bypass. More vitamin deficiency is noted with LOOP DS. The follow-up rate after LOOP DS is significantly higher than follow-up with other procedures. Background: The aim of this study is to determine if implementation of an ERAS protocol can improve outcomes of laparoscopic sleeve gastrectomy (LSG) in adolescents. Methods: A retrospective analysis of 100 adolescent patients who underwent LSG from February 2011 to April 2019 was conducted. An ERAS protocol was instituted in 2016. Conventional care patients (n551) were compared with ERAS patients (n549). Patient demographic and clinical characteristics were reported as median for continuous variables, or counts and percentages for categorical variables. Comparisons were made using Chi-squared tests or Fisher's exact for categorical data and Wilcoxon-rank sum tests for continuous data. Multiple linear regression was used to adjust LOS (days) for age at surgery, gender, payer status, race/ethnicity, ASA, and pre-op BMI. LOS was log-transformed for normality. Results: There were no significant differences in patient characteristics. Intraoperative fluid volume, intra-and post-operative narcotics were lower in the ERAS group (p,0.0001). The number of ERAS elements per patient increased from 9 to 15 (p,0.0001). The ERAS group had more discharges at post-operative day 1 (45% vs 6 %, respectively). LOS was significantly lower in the ERAS group (2.34 vs. 2.06 days, respectively). Differences were significant (p,0.0001) after adjusting for age, gender, pre-op BMI, ASA, race/ethnicity. There were no differences in post-operative complications and 30 day readmissions. Conclusion: A LSG ERAS protocol is associated with a significant reduction in perioperative narcotic use and LOS with no increase in complications or readmission rates.
